Clinical trials
Completed Sarcoma, Kaposi trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
102 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 5 |
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 102 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 21 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 17 |
| AIDS Malignancy Consortium | 6 |
| Daiichi Pharmaceuticals | 4 |
| University of California, San Francisco | 4 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Sequus Pharmaceuticals | 3 |
| Anderson Clinical Research | 2 |
| National Institutes of Health Clinical Center (CC) | 2 |
| Navidea Biopharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma, Kaposi | 102 |
| HIV Infections | 53 |
| Acquired Immunodeficiency Syndrome | 48 |
| Sarcoma | 22 |
| Neoplasms | 14 |
| Skin Neoplasms | 10 |
| Lymphoma, Non-Hodgkin | 7 |
| Osteosarcoma | 7 |
| Chondrosarcoma | 6 |
| Melanoma | 6 |
Trials
Showing 51 to 75 of 102. Each trial links to its page on Pharma Observatory.
2 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.